Literature DB >> 4793334

An analysis of the learning deficit following hyoscine administration to man.

T J Crow, I G Grove-White.   

Abstract

1. Twelve volunteer subjects completed a free-recall word learning test, a number-colour association test, and a scanning task after the following treatments: saline 1 ml, hyoscine 0.4 mg, or atropine 0.6 mg, administered by intravenous injection.2. Performance on all three tests was not significantly impaired after atropine.3. Performance on the two learning tests but not on the scanning task, was significantly impaired after hyoscine.4. Analysis of the results of the free-recall word learning test indicates that impairment of learning following hyoscine does not affect recall over intervals of a few seconds, but affects that portion of the learning curve which has been attributed to long-term (or secondary) rather than short-term (or primary) memory.5. The results suggest that hyoscine 0.4 mg may impair learning processes, without significantly depressing other psychological functions, and that the impairment of learning following hyposcine does not affect recall over intervals memory.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4793334      PMCID: PMC1776392          DOI: 10.1111/j.1476-5381.1973.tb08379.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  10 in total

Review 1.  PRIMARY MEMORY.

Authors:  N C WAUGH; D A NORMAN
Journal:  Psychol Rev       Date:  1965-03       Impact factor: 8.934

2.  The amnesic properties of hyoscine and atropine in pre-anaesthetic medication.

Authors:  T K HARDY; D WAKELY
Journal:  Anaesthesia       Date:  1962-07       Impact factor: 6.955

3.  Postoperative amnesia.

Authors:  W LAMBRECHTS; J PARKHOUSE
Journal:  Br J Anaesth       Date:  1961-08       Impact factor: 9.166

Review 4.  Primary memory.

Authors:  F I Craik
Journal:  Br Med Bull       Date:  1971-09       Impact factor: 4.291

Review 5.  The relation between long-term and short-term memory.

Authors:  A D Baddeley; K Patterson
Journal:  Br Med Bull       Date:  1971-09       Impact factor: 4.291

6.  Amnesia studies with intravenous premedication.

Authors:  S K Pandit; J W Dundee; S R Keilty
Journal:  Anaesthesia       Date:  1971-10       Impact factor: 6.955

7.  Pre-operative amnesia. The incidence following the intramuscular injection of commonly used premedicants.

Authors:  S K Pandit; J W Dundee
Journal:  Anaesthesia       Date:  1970-10       Impact factor: 6.955

Review 8.  Behavioral and electroencephalographic effects of atropine and related compounds.

Authors:  V G Longo
Journal:  Pharmacol Rev       Date:  1966-06       Impact factor: 25.468

9.  Differential effect of atropine and hyoscine on human learning capacity.

Authors:  T J Crow; I G Grove-White; G R Kelman
Journal:  Br J Pharmacol       Date:  1971-10       Impact factor: 8.739

10.  A comparison of some atropine-like drugs in man, with particular reference to their end-organ specificity.

Authors:  A HERXHEIMER
Journal:  Br J Pharmacol Chemother       Date:  1958-06
  10 in total
  29 in total

Review 1.  Neuromodulation by glutamate and acetylcholine can change circuit dynamics by regulating the relative influence of afferent input and excitatory feedback.

Authors:  Lisa M Giocomo; Michael E Hasselmo
Journal:  Mol Neurobiol       Date:  2007-07-20       Impact factor: 5.590

2.  A comparison of the effects of scopolamine and diazepam on working memory.

Authors:  J M Rusted; P Eaton-Williams; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

3.  Distinguishing between attentional and amnestic effects in information processing: the separate and combined effects of scopolamine and nicotine on verbal free recall.

Authors:  J Rusted; P Eaton-Williams
Journal:  Psychopharmacology (Berl)       Date:  1991       Impact factor: 4.530

4.  The effects of transdermal scopolamine and four dose levels of oral scopolamine (0.15, 0.3, 0.6, and 1.2 mg) upon psychological performance.

Authors:  A C Parrott
Journal:  Psychopharmacology (Berl)       Date:  1986       Impact factor: 4.530

5.  Effects of scopolamine and physostigmine on recognition memory in monkeys with ibotenic-acid lesions of the nucleus basalis of Meynert.

Authors:  T G Aigner; S J Mitchell; J P Aggleton; M R DeLong; R G Struble; D L Price; G L Wenk; M Mishkin
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

Review 6.  Mechanisms underlying working memory for novel information.

Authors:  Michael E Hasselmo; Chantal E Stern
Journal:  Trends Cogn Sci       Date:  2006-10-02       Impact factor: 20.229

7.  The effects of scopolamine and clonidine upon the performance and learning of a motor skill.

Authors:  C D Frith; M A McGinty; I Gergel; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

8.  Changes in the human visual evoked potential caused by the anticholinergic agent hyoscine hydrobromide: comparison with results in Alzheimer's disease.

Authors:  A A Bajalan; C E Wright; V J van der Vliet
Journal:  J Neurol Neurosurg Psychiatry       Date:  1986-02       Impact factor: 10.154

9.  Effects of scopolamine and nicotine on human rapid information processing performance.

Authors:  K Wesnes; D M Warburton
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

10.  Cholinergic learning deficits in the marmoset produced by scopolamine and ICV hemicholinium.

Authors:  R M Ridley; N G Barratt; H F Baker
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.